Most cardiotoxic local anaesthetic agent
**Core Concept**
Bupivacaine is a long-acting local anesthetic agent that can cause cardiotoxicity due to its ability to block sodium channels in the heart, leading to a potentially fatal arrhythmia known as torsades de pointes.
**Why the Correct Answer is Right**
Bupivacaine's high lipid solubility allows it to easily penetrate the cardiac cell membrane and bind to sodium channels, causing a rapid influx of sodium ions into the cell. This leads to a prolonged depolarization of the cardiac myocyte, resulting in a dangerous arrhythmia. The high potency and rapid onset of bupivacaine's cardiotoxic effects make it the most cardiotoxic local anesthetic agent.
**Why Each Wrong Option is Incorrect**
**Option A:** **Lidocaine** is actually used to treat ventricular tachycardia and has a lower risk of cardiotoxicity compared to bupivacaine.
**Option B:** **Mepivacaine** has a lower lipid solubility than bupivacaine, which reduces its cardiotoxic potential.
**Option C:** **Ropivacaine** is a newer local anesthetic agent with a lower potency and lower risk of cardiotoxicity compared to bupivacaine.
**Clinical Pearl / High-Yield Fact**
When administering local anesthetics, it's essential to monitor the patient's cardiac rhythm and be prepared to treat any signs of cardiotoxicity, such as arrhythmias or hypotension.
**Correct Answer: C. Ropivacaine**